Literature DB >> 1322872

Reduction of plasma insulin levels does not restore integrated concentration of growth hormone to normal in obese children.

S A Chalew1, R A Lozano, K M Armour, A A Kowarski.   

Abstract

Obesity in childhood is characterized by subnormal integrated concentrations of growth hormone (IC-GH) and elevated integrated concentrations of insulin (IC-I). We tested whether a reduction of IC-I induced by a low calorie diet would lead to a rise of IC-GH into the normal range for age. Six obese children (body mass index (BMI) 39.1 +/- 9.2 kg/m2) underwent integrated concentration (IC) studies by continuous withdrawal before and again 5-8 weeks after being on a low calorie diet. In response to the diet BMI was lower 34.7 +/- 9.4 kg/m2 (P less than 0.003), and IC-I was considerably reduced, 479 +/- 255 pM initially vs. 109 +/- 109 pM on the diet, P less than 0.0008. IC-GH increased modestly from 1.6 +/- 0.6 micrograms/l initially to 2.4 +/- 0.6 micrograms/l, P less than 0.01 on the diet. None of the patients had repeat IC-GH levels which were above the lower limit of normal for lean children of normal stature (3.2 micrograms/l). Single sample insulin-like growth factor 1 (IGF-1) levels were unchanged: 40.9 +/- 23.1 nM initially vs. 49.7 +/- 25.7 nM (314.6 +/- 197.7 vs. 382.5 +/- 217.0 ng/ml, n.s.). Thus reduction of high insulin concentrations during 5-8 weeks of a low calorie diet has only a small effect on IC-GH in obese children. Factors other than circulating insulin levels are likely to play the major role in mediating the reduced levels of GH observed in obesity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322872

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  1 in total

1.  The 24-hour average concentration of cortisol is elevated in obese African-American youth with type 2 diabetes.

Authors:  Pinar Gumus Balikcioglu; Metin Balikcioglu; Arlette Soros; Stuart Chalew
Journal:  J Diabetes Complications       Date:  2021-04-16       Impact factor: 3.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.